HemaSphere (Jun 2022)

P359: IMPROVED OVERALL SURVIVAL AND MRD CLEARANCE WITH BLINATUMOMAB VS CHEMOTHERAPY AS PRE-TRANSPLANT CONSOLIDATION IN PEDIATRIC HIGH-RISK FIRST-RELAPSE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)

  • F. Locatelli,
  • G. Zugmaier,
  • C. Rizzari,
  • J. Morris,
  • B. Gruhn,
  • T. Klingebiel,
  • R. Parasole,
  • C. Linderkamp,
  • C. Flotho,
  • A. Petit,
  • C. Micalizzi,
  • Y. Zeng,
  • R. Desai,
  • W. Kormany,
  • C. Eckert,
  • A. Möricke,
  • M. Sartor,
  • O. Hrusak,
  • C. Peters,
  • V. Saha,
  • L. Vinti,
  • A. von Stackelberg

DOI
https://doi.org/10.1097/01.HS9.0000844324.04051.5b
Journal volume & issue
Vol. 6
pp. 259 – 260

Abstract

Read online

No abstracts available.